Predicting liver fibrosis with non-invasive test: A hope for the future;Predicción de fibrosis hepática con pruebas no invasivas. Una apuesta de futuro

Revista Espanola de Enfermedades Digestivas

Volumn 100, Issue 10, 2008, Pages 605-610

  Gabriel, J C Marín ^a   Herrazo, J A Soíls ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS; CELL INVASION; EDITORIAL; HEMOCHROMATOSIS; HEPATITIS C VIRUS; HUMAN; LIVER BIOPSY; LIVER FIBROSIS; MORPHOLOGY; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PORTAL HYPERTENSION; BLOOD; CHEMISTRY; DISEASE COURSE; FORECASTING; GENETICS; HEPATITIS C; LIVER; LIVER CIRRHOSIS; METABOLISM; PATHOLOGY; PHENOTYPE; PREDICTION AND FORECASTING; SENSITIVITY AND SPECIFICITY;

AMINOTRANSFERASE; BIOLOGICAL MARKER; FERRITIN; IRON;

BIOLOGICAL MARKERS; DISEASE PROGRESSION; FERRITINS; FORECASTING; HEMOCHROMATOSIS; HEPATITIS C, CHRONIC; HUMANS; IRON; LIVER; LIVER CIRRHOSIS; MAGNETIC RESONANCE IMAGING; PHENOTYPE; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; TRANSAMINASES;

EID: 58749091650     PISSN: 11300108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (28)

1. Rockey DC, Bissell DM. Non-invasive measures of liver fibrosis. Hepatology 2006; 43 (2 Supl. 1): S113-S120.
2. Urtasun R, Nieto N. Hepatic stellate cells and oxidative stress. Rev Esp Enferm Dig 2007; 99 (4): 223-230
3. Romero-Gómez M. Hepatitis C and insulin resistance: steatosis, fibrosis and non-response. Rev Esp Enferm Dig 2006; 98 (8): 605-615
4. Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet 1997; 349 (9055): 825-832
5. Hubscher SG. Histological grading and staging in chronic hepatitis: clinical applications and problems. J Hepatol 1998; 29 (6): 1015-1022
6. Froehlich F, Lamy O, Fried M, Gonvers JJ. Practice and complications of liver-biopsy - Results of a nationwide survey in Switzerland. Digestive Diseases and Sciences 1993; 38 (8): 1480-1484
7. Thampanitchawong P, Piratvisuth T. Liver biopsy: complications and risk factors. World J Gastroenterol 1999; 5 (4): 301-304
8. Terjung B, Lemnitzer I, Dumoulin FL, Effenberger W, Brackmann HH, Sauerbruch T, et al. Bleeding complications after percutaneous liver biopsy. Digestion 2003; 67 (3): 138-145
9. Colloredo G, Guido M, Sonzogni A, Leandro G. Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease. J Hepatol 2003; 39 (2): 239-244
10. Regev A, Berho M, Jeffers LJ, Milikowski C, Molina EG, Pyrsopoulos NT, et al. Sampling error and intraob-server variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 2002; 97 (10): 2614-2618
11. Bedossa P, Dargere D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 2003; 38 (6): 1449-1457
12. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. The French METAVIR Cooperative Study Group. Hepatology 1994; 20 (1 Pt 1): 15-20.
13. Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003; 38 (2): 518-526
14. Forns X, Ampurdanes S, Llovet JM, Aponte J, Quinto L, Martinez-Bauer E, et al. Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. Hepatology 2002; 36 (4): 986-992
15. Imbert-Bismut F, Ratziu V, Pieroni L, Charlotte F, Benhamou Y, Poynard T, et al. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet 2001; 357 (9262): 1069-1075
16. Lok ASF, Ghany MG, Goodman ZD, Wright EC, Everson GT, Sterling RK, et al. Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests: Results of the HALT-C cohort. Hepatology 2005; 42 (2): 282-292
17. Parkes J, Guha IN, Roderick P, Rosenberg W. Performance of serum marker panels for liver fibrosis in chronic hepatitis C. J Hepatol 2006; 44 (3): 462-474
18. Castiella A, Zapata E, Otazua P, Fernández J, Alustiza JM, Ugarte M, et al. Utilidad de los diferentes métodos no invasivos de predicción de fibrosis hepática en pacientes del País Vasco con hemocromatosis fenotípica. Rev Esp Enferm Dig 2008; 100 (10): 611-614
19. Jaeschke R, Guyatt GH, Sackett DL. Users' guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working Group. JAMA 1994; 271 (9): 703-707
20. Beaton M, Adams PC. Assessment of silent liver fibrosis in hemochromatosis C282Y homozygotes with normal transaminase levels. Clin Gastroenterol Hepatol 2008; 6 (6): 713-714
21. Beaton M, Guyader D, Deugnier Y, Moirand R, Chakrabarti S, Adams P. Noninvasive prediction of cirrhosis in C282Y-linked hemochromatosis. Hepatology 2002; 36 (3): 673-678
22. Guyader D, Jacquelinet C, Moirand R, Turlin B, Mendler MH, Chaperon J, et al. Noninvasive prediction of fibrosis in C282Y homozygous hemochromatosis. Gastroenterology 1998; 115 (4): 929-936
23. George DK, Ramm GA, Walker NI, Powell LW, Crawford DH. Elevated serum type IV collagen: a sensitive indicator of the presence of cirrhosis in haemochromatosis. J Hepatol 1999; 31 (1): 47-52.
24. Alústiza JM, Artetxe J, Castiella A, Agirre C, Emparanza JI, Otazua P, et al. MR quantification of hepatic iron concentration. Radiology 2004; 230 (2): 479-484
25. Olynyk JK, St Pierre TG, Britton RS, Brunt EM, Bacon BR. Duration of hepatic iron exposure increases the risk of significant fibrosis in hereditary hemochromatosis: a new role for magnetic resonance imaging. Am J Gastroenterol 2005; 100 (4): 837-841
26. Castiella A, Emparanza JI. External validation for fibrosis predicting index in hereditary hemochromatosis. Am J Gastroenterol 2005; 100 (10): 2366-2367
27. Mirault T, Lucidarme D, Turlin B, Vandevenne P, Gosset P, Ernst O, et al. Non-invasive assessment of liver fibrosis by transient elastography in post transfusional iron overload. Eur J Haematol 2008; 80 (4): 337-40.
28. Adhoute X, Foucher J, Laharie D, Terrebonne E, Vergniol J, Castera L, et al. Diagnosis of liver fibrosis using FibroScan and other noninvasive methods in patients with hemochromatosis: a prospective study. Gastroenterol Clin Biol 2008; 32 (2): 180-187.